Eurofins Scientific SE (EPA:ERF)

Market Cap	9.18B
Revenue (ttm)	6.95B
Net Income (ttm)	356.00M
Shares Out	188.05M
EPS (ttm)	1.83
PE Ratio	26.67
Forward PE	13.49
Dividend	0.60 (1.21%)
Ex-Dividend Date	Jul 3, 2024

Volume	346,243
Average Volume	385,749
Open	49.38
Previous Close	49.44
Day's Range	48.72 - 49.71
52-Week Range	39.47 - 62.10
Beta	0.72
RSI	44.69
Earnings Date	Jan 30, 2025

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 63,000
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2024, Eurofins Scientific SE's revenue was 6.95 billion, an increase of 6.70% compared to the previous year's 6.51 billion. Earnings were 356.00 million, an increase of 38.79%.